jrnl6660

Publication Venue For

  • Mitochondrial DNA mutations and cardiovascular disease.  32:267-274. 2017
  • Stem cells in the management of advanced heart failure.  30:179-185. 2015
  • Ovarian hormones and vascular disease.  28:411-416. 2013
  • Serum urate: A biomarker or treatment target in pediatric hypertension?.  28:433-438. 2013
  • Sudden cardiac death in young athletes: What is the role of screening?.  28:55-62. 2013
  • Blood pressure and human genetic variation in the general population.  25:229-237. 2010
  • Resistant hypertension: Who and how to evaluate.  24:340-344. 2009
  • Adenosine single photon emission computed tomography for assessing risk after myocardial infarction: Recent developments.  22:401-407. 2007
  • Perspectives on dyslipidemia and coronary heart disease in women: An update.  21:602-607. 2006
  • Mechanical circulatory support therapy as a bridge to transplant or recovery (new advances).  21:120-126. 2006
  • Xenotransplantation: An ethical dilemma.  21:138-141. 2006
  • Is biopsy-proven cellular rejection an important clinical consideration in heart transplantation?.  20:127-131. 2005
  • Cellular transplantation: Hurdles remaining before widespread clinical use.  19:154-161. 2004
  • The potential role of xenotransplantation in treating endstage cardiac disease: A summary of the report of the Xenotransplantation Advisory Committee of the International Society for Heart and Lung Transplantation.  16:105-109. 2001
  • New strategies in myocardial preservation.  12:504-514. 1997
  • Predicting outcome after cardiac transplantations: Lessons from the Cardiac Transplant Research Database.  12:136-145. 1997
  • The inflammatory response to cardiopulmonary bypass and its impact on postoperative myocardial function.  10:597-604. 1995
  • Alternatives to human heart replacement.  10:218-222. 1995
  • What is the optimal tool to define appropriate therapy: The randomized clinical trial, meta-analysis, or outcomes research?.  9:401-403. 1994
  • Pathogenesis of atherosclerosis.  9:404-410. 1994
  • Primary and secondary prevention of ischemic heart disease.  9:417-427. 1994
  • Ischemic heart disease.  8:553-556. 1993
  • The role of nuclear imaging in ischemic heart disease.  8:562-571. 1993
  • Echocardiography in coronary artery disease.  7:582-586. 1992
  • Ischemic heart disease.  7:537-540. 1992
  • Long-term results of coronary artery bypass grafting.  7:990-996. 1992
  • Nuclear cardiac imaging.  6:953-964. 1991
  • Nuclear magnetic resonance imaging of the cardiovascular system.  4:845-852. 1989